Termination Reimbursement scheme Broxil®
From August 1, 2025 Broxil® 125 mg / 5 mL, powder for oral suspension is fully reimbursed by the health insurance. For this reason the reimbursement scheme for Broxil® powder for oral suspension will terminate the 1st of August.
Conditions
Now that the reimbursement scheme for Broxil® powder for oral suspension will be terminated, claims with an issue date before August 1, 2025 can be submitted until December 31, 2025. After that, no more claims can be processed.
Who can submit a claim
Only patients or their carer can submit a claim for the Personal Contribution paid for Broxil® powder for oral suspension, either online or by post by means of the detailed statement from their health insurer. Online will be the fastest option. Pharmacists cannot submit claims for this medicine on behalf of the patient.
For more information check out the Broxil® 125 mg / 5 mL, powder for oral suspension Medicine page